VRTX - Vertex Pharmaceuticals Inc / Ma - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - VRTX (875320)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
95 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-03-17
VRTXWagner Charles F JrEVP, CFOS - Sale$296.39-2,00051,379-4%-$592,786
2023-03-16
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$300.59-2,74649,268-5%-$825,423
M
2023-03-10
VRTXWagner Charles F JrEVP, CFOS - Sale$291.98-4,75453,379-8%-$1,388,054
2023-02-27
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$287.48-35456,805-1%-$101,768
2023-02-27
VRTXArbuckle Stuart AEVP, COOS - Sale$287.47-5,03456,696-8%-$1,447,143
2023-02-27
VRTXAmbrose KristenSVP, Chief Accounting OfficerS - Sale$287.55-1,2077,303-14%-$347,072
2023-02-27
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$287.51-4,23832,038-12%-$1,218,449
2023-02-22
VRTXArbuckle Stuart AEVP, COOS - Sale$294.33-2,40166,444-3%-$706,679
2023-02-21
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$293.75-48060,467-1%-$141,002
2023-02-21
VRTXArbuckle Stuart AEVP, COOS - Sale$293.75-2,40268,845-3%-$705,596
2023-02-21
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$293.77-4,00240,246-9%-$1,175,676
2023-02-14
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$298.52-32065,4450%-$95,527
2023-02-14
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$300.40-2,18159,734-4%-$655,161
2023-02-14
VRTXArbuckle Stuart AEVP, COOS - Sale$298.68-6,39875,745-8%-$1,910,962
2023-02-14
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$298.70-6,39847,998-12%-$1,911,108
2023-02-13
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$298.99-27565,7650%-$82,223
2023-02-13
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$300.39-11361,9150%-$33,944
2023-02-13
VRTXArbuckle Stuart AEVP, COOS - Sale$298.92-4,88782,143-6%-$1,460,816
2023-02-13
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$298.90-4,79854,396-8%-$1,434,126
D
2023-02-06
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$306.00-1,30468,645-2%-$399,022
2023-01-31
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$325.00-10637,9980%-$34,450
D
2023-01-31
VRTXSachs Bruce IDirS - Sale+OE$325.01-1,20041,210-3%-$390,012
2023-01-30
VRTXCarney LloydDirS - Sale$320.52-2,7004,150-39%-$865,406
D
2023-01-27
VRTXLee YuchunDirS - Sale+OE$322.03-1,4291,875-43%-$460,177
DM
2023-01-25
VRTXLee YuchunDirS - Sale+OE$316.15-8,0001,875-81%-$2,529,174
2023-01-25
VRTXKewalramani ReshmaCEO, PresS - Sale$315.05-10,00089,598-10%-$3,150,500
DM
2023-01-23
VRTXLee YuchunDirS - Sale+OE$312.46-6,1291,875-77%-$1,915,044
DM
2023-01-17
VRTXLee YuchunDirS - Sale+OE$312.04-4,4421,875-70%-$1,386,099
2022-11-15
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$308.61-3436,0770%-$10,493
D
2022-11-07
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$303.04-1,30336,077-3%-$394,859
2022-11-02
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$312.64-32038,104-1%-$100,045
2022-10-24
VRTXBhatia Sangeeta N.DirS - Sale$310.00-6214,040-13%-$192,510
2022-10-18
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$300.31-1,79139,192-4%-$537,860
2022-08-15
VRTXKewalramani ReshmaCEO, PresS - Sale$305.06-11,68999,598-11%-$3,565,846
D
2022-08-15
VRTXArbuckle Stuart AEVP, COOS - Sale+OE$303.93-22,17345,418-33%-$6,738,991
2022-08-15
VRTXLiu JoySVP, GCS - Sale$303.90-3,7479,605-28%-$1,138,723
D
2022-08-10
VRTXArbuckle Stuart AEVP, COOS - Sale+OE$300.41-18061,0200%-$54,073
2022-08-10
VRTXLiu JoySVP, GCS - Sale$300.32-3613,3520%-$10,812
2022-08-08
VRTXBhatia Sangeeta N.DirS - Sale$293.03-6214,661-12%-$181,972
2022-08-09
VRTXLiu JoySVP, GCS - Sale$300.00-94613,388-7%-$283,800
2022-08-09
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$298.97-1,40046,090-3%-$418,557
D
2022-08-09
VRTXArbuckle Stuart AEVP, COOS - Sale+OE$300.67-5,69061,136-9%-$1,710,817
D
2022-08-08
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$292.54-1,30436,077-3%-$381,469
2022-07-29
VRTXBhatia Sangeeta N.DirS - Sale$278.77-6215,282-11%-$173,116
D
2022-07-25
VRTXLeiden Jeffrey MExec COBS - Sale+OE$281.38-132,0792,863-98%-$37,164,481
D
2022-07-19
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$288.65-17,86536,077-33%-$5,156,730
2022-06-24
VRTXKewalramani ReshmaCEO, PresS - Sale$291.30-11,689111,153-10%-$3,405,006
2022-05-16
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$252.83-4541,7490%-$11,377
2022-05-16
VRTXArbuckle Stuart AEVP, COOS - Sale$251.19-13364,9000%-$33,408
2022-05-16
VRTXLiu JoySVP, GCS - Sale$252.88-13314,334-1%-$33,633
2022-05-04
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$275.09-3641,6600%-$9,903
2022-05-02
VRTXArbuckle Stuart AEVP, COOS - Sale$263.98-30664,9000%-$80,778
2022-05-02
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$259.16-32041,696-1%-$82,930
2022-05-02
VRTXBhatia Sangeeta N.DirS - Sale$258.95-7375,903-11%-$190,842
2022-05-02
VRTXWagner Charles F JrEVP, CFOS - Sale$258.83-34342,730-1%-$88,778
2022-04-29
VRTXLiu JoySVP, GCS - Sale$275.41-12014,334-1%-$33,049
2022-04-25
VRTXAmbrose KristenSVP, Chief Accounting OfficerS - Sale$269.55-3273,496-9%-$88,143
D
2022-04-18
VRTXLee YuchunDirS - Sale+OE$284.23-2,0001,875-52%-$568,467
D
2022-04-14
VRTXLee YuchunDirS - Sale+OE$289.06-2,0001,875-52%-$578,117
2022-04-13
VRTXLeiden Jeffrey MExec COBS - Sale$289.04-15,78974,600-17%-$4,563,653
DM
2022-04-12
VRTXLee YuchunDirS - Sale+OE$284.27-4,0001,875-68%-$1,137,060
DM
2022-04-08
VRTXLee YuchunDirS - Sale+OE$279.44-4,0001,875-68%-$1,117,740
D
2022-04-08
VRTXBhatia Sangeeta N.DirS - Sale+OE$280.20-1,9075,191-27%-$534,341
D
2022-04-08
VRTXMcGlynn Margaret GDirS - Sale+OE$280.22-5,0001,099-82%-$1,401,080
DM
2022-04-06
VRTXLee YuchunDirS - Sale+OE$273.24-4,0001,875-68%-$1,092,964
2022-04-07
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$276.18-56142,782-1%-$154,935
M
2022-04-04
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$274.10-3,72543,343-8%-$1,021,005
DM
2022-04-04
VRTXLee YuchunDirS - Sale+OE$270.11-4,0001,875-68%-$1,080,424
2022-04-01
VRTXWagner Charles F JrEVP, CFOS - Sale$264.76-2,58243,620-6%-$683,602
D
2022-03-31
VRTXMcGlynn Margaret GDirS - Sale+OE$262.27-5,0001,099-82%-$1,311,346
2022-03-17
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$250.11-2,83347,356-6%-$708,572
2022-03-17
VRTXWagner Charles F JrEVP, CFOS - Sale$250.15-3,17146,202-6%-$793,218
2022-03-17
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$250.06-2,12248,412-4%-$530,627
2022-02-25
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$230.95-32550,189-1%-$75,058
2022-02-18
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$231.00-51953,104-1%-$119,889
2022-02-18
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$230.97-4,31249,687-8%-$995,949
2022-02-14
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$232.02-2,44457,438-4%-$567,057
2022-02-02
VRTXWagner Charles F JrEVP, CFOS - Sale$250.07-2,94457,435-5%-$736,206
2022-02-02
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$250.98-1,04054,952-2%-$261,017
D
2022-02-02
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$251.47-4,66065,697-7%-$1,171,842
D
2022-01-28
VRTXMcGlynn Margaret GDirS - Sale+OE$241.79-5,0001,099-82%-$1,208,960
2021-11-15
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale$187.19-5148,3830%-$9,547
2021-11-15
VRTXArbuckle Stuart AEVP, COOS - Sale$187.26-341,2430%-$562
2021-11-15
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$187.22-3433,5890%-$6,365
2021-08-19
VRTXKewalramani ReshmaCEO, PresP - Purchase$195.65+10,00073,754+16%+$1,956,492
2021-08-02
VRTXSachs Bruce IDirP - Purchase$197.91+15,00041,210+57%+$2,968,650
2021-06-02
VRTXBhatia Sangeeta N.DirS - Sale$209.69-5595,191-10%-$117,216
2021-05-17
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$216.34-11234,1080%-$24,230
2021-05-17
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale$216.35-4548,3830%-$9,736
2021-05-17
VRTXLiu JoySVP, GCS - Sale$216.34-1128,253-1%-$24,230
2021-05-17
VRTXArbuckle Stuart AEVP, Chief Comm, Ops OfficerS - Sale$216.41-10941,2430%-$23,589
2021-05-17
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$216.36-7933,5890%-$17,093
2021-05-03
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$218.43-96034,108-3%-$209,691
D
2021-04-27
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale+OE$216.06-3,88448,383-7%-$839,193
2021-04-05
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$214.14-1,68635,834-4%-$361,046

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top